[1]
B, T. and B, T. 2023. Formulation And Evaluation of Mucoadhesive Buccal Tablets (Repaglinide) For Management of Diabetes. International Journal of Pharmacy Research & Technology (IJPRT). 12, 1 (Mar. 2023), 75–92.